You are here

US drug giant Amgen opens first next-gen facility in Tuas

BT_20141121_CHAMGEN21_1377583.jpg
Mr Lim (in purple tie) at the 120,000 square foot Tuas plant on Thursday, accompanied by Robert Bradway, Amgen chairman and chief executive officer, and Kimball Hall (extreme right), Amgen vice-president, manufacturing.

Singapore

AMERICAN drug-maker Amgen expects to roll out its products for treating osteoporosis and bone cancers from its new plant in Tuas by the end of 2016. The S$200 million plant in Tuas Biomedical Park is the first next-generation biomanufacturing facility in the world, and is the

sentifi.com

Market voices on:

grab

Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at btsub.sg/promo

Powered by GET.comGetCom